Comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study

被引:12
|
作者
Farmer, Cristan [1 ]
Thurm, Audrey [1 ]
Troy, Jesse D. D. [2 ]
Kaat, Aaron J. J. [3 ]
机构
[1] Natl Inst Mental Hlth, Neurodev & Behav Phenotyping Serv, Bethesda, MD 20892 USA
[2] Duke Univ, Dept Biostat & Bioinformat, Sch Med, Durham, NC USA
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
基金
美国国家卫生研究院;
关键词
Ability score; Growth scale value; Rasch analysis; Item response theory; Neurodevelopmental disability; Rare genetic condition; Floor effect; Clinical trials; Clinical outcome assessment; Endpoints; ITEM RESPONSE THEORY;
D O I
10.1186/s11689-022-09474-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundFor genetic conditions associated with neurodevelopmental disorder (GCAND), developmental domains such as motor ability, thinking and learning, social abilities, and communication are potential intervention targets. Performance on measures of developmental concepts can be expressed using several types of scores. Norm-referenced scores are intended for the diagnostic context, allowing for the identification of impairment relative to age-based expectations, and can exhibit dramatic floor effects when used in individuals with more significant limitations. Person ability scores, which are derived via Rasch analysis or item response theory, are available on many standardized tests and are intended to measure within-person change. However, they have not been used or evaluated as primary endpoints in GCAND clinical trials. In this study, we simulated a series of parallel-arm clinical trials under several chronological age and impairment conditions, to compare empirically the power and type I error rate of operationalizing test performance using ability scores rather than norm-referenced scores.ResultsUsing the Vineland Adaptive Behavior Scales as the example, we demonstrated an advantage in statistical power of ability scores over norm-referenced scores at extreme levels of impairment. This advantage was at least partially driven by floor effects in norm-referenced scores. For simulated conditions where impairment was less severe, ability scores outperformed norm-referenced scores, but they were more similar. The type I error rate closely approximated the nominal type I error rate of 5% for both scores.ConclusionThe results of this simulation demonstrate a substantial power and interpretative advantage of ability scores over norm-referenced scores for studies of GCAND that will enroll participants with high levels of impairment. These results are expected to generalize to studies of developmental concepts, regardless of the etiology or specific test. However, the relative advantage of ability scores is expected to be even greater for tests with a higher floor than the Vineland.
引用
收藏
页数:9
相关论文
共 40 条
  • [31] Clinical trial protocol for P-NeLoP: a randomized controlled trial comparing the feasibility and outcomes of robot-assisted partial nephrectomy with low insufflation pressure using AirSeal versus standard insufflation pressure (UroCCR no. 85 study)
    Margue, Gaelle
    Bigot, Pierre
    Ingels, Alexandre
    Roupret, Morgan
    Waeckel, Thibaut
    Long, Jean-Alexandre
    Pignot, Geraldine
    Bensalah, Karim
    Lang, Herve
    Olivier, Jonathan
    Bruyere, Franck
    Durand, Matthieu
    Beauval, Jean-Baptiste
    Mallet, Richard
    Parier, Bastien
    De La Taille, Alexandre
    Bernhard, Jean-Christophe
    TRIALS, 2023, 24 (01)
  • [32] CASS (CyanoAcrylate closure versus Surgical Stripping for incompetent saphenous veins) study: a randomized controlled trial comparing clinical outcomes after cyanoacrylate closure and surgical stripping for the treatment of incompetent saphenous veins
    Sungsin Cho
    Hyung Sub Park
    Taeseung Lee
    Seung Jae Byun
    Woo-Sung Yun
    Shin-Seok Yang
    Hyangkyoung Kim
    Woo-Shik Kim
    Jin Hyun Joh
    In Mok Jung
    Trials, 21
  • [33] The South Asian cataract management study: Complications, vision outcomes, and corneal endothelial cell loss in a randomized multicenter clinical trial comparing intracapsular cataract extraction with and without anterior chamber intraocular lens implantation
    Snellingen, T
    Shrestha, JK
    Huq, F
    Husain, R
    Koirala, S
    Rao, GN
    Pokhrel, RP
    Kolstad, A
    Upadhyay, MP
    Apple, DJ
    Arnesen, E
    Cheng, H
    Olsen, EG
    Vogel, M
    OPHTHALMOLOGY, 2000, 107 (02) : 231 - 240
  • [34] Randomized Clinical Trial Comparing On-clamp Versus Off-clamp Laparoscopic Partial Nephrectomy for Small Renal Masses (CLOCK II Laparoscopic Study): A Intention-to-treat Analysis of Perioperative Outcomes
    Bertolo, Riccardo
    Bove, Pierluigi
    Sandri, Marco
    Celia, Antonio
    Cindolo, Luca
    Cipriani, Chiara
    Falsaperla, Mario
    Leonardo, Costantino
    Mari, Andrea
    Parma, Paolo
    Veccia, Alessandro
    Veneziano, Domenico
    Minervini, Andrea
    Antonelli, Alessandro
    EUROPEAN UROLOGY OPEN SCIENCE, 2022, 46 : 75 - 81
  • [35] Identification of patient subgroups with unfavorable long-term outcomes associated with laparoscopic surgery in a randomized controlled trial comparing open and laparoscopic surgery for colon cancer (Japan Clinical Oncology Group Study JCOG0404)
    Saito, Shuji
    Akagi, Tomonori
    Katayama, Hiroshi
    Wakabayashi, Masashi
    Inomata, Masafumi
    Yamamoto, Seiichiro
    Ito, Masaaki
    Kinugasa, Yusuke
    Egi, Hiroyuki
    Munakata, Yasuhiro
    Kokuba, Yukihito
    Bando, Hiroyuki
    Yasui, Masayoshi
    Ikeda, Masataka
    Nakajima, Kentaro
    Shida, Dai
    Kanemitsu, Yukihide
    Kitano, Seigo
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2021, 5 (06): : 804 - 812
  • [36] Ten-year clinical outcomes from a randomized trial comparing new-generation everolimus-eluting stent versus first-generation Sirolimus-eluting stent: Results from the RESET extended study
    Shiomi, Hiroki
    Kozuma, Ken
    Morimoto, Takeshi
    Kadota, Kazushige
    Tanabe, Kengo
    Morino, Yoshihiro
    Tamura, Toshihiro
    Abe, Mitsuru
    Suwa, Satoru
    Ito, Yoshiaki
    Kobayashi, Masakazu
    Dai, Kazuoki
    Nakao, Koichi
    Tarutani, Yasuhiro
    Taniguchi, Ryoji
    Nishikawa, Hideo
    Yamamoto, Yoshito
    Yamasaki, Tomohiro
    Okamura, Atsunori
    Nakagawa, Yoshihisa
    Ando, Kenji
    Kobayashi, Koichi
    Kawai, Kazuya
    Hibi, Kiyoshi
    Kimura, Takeshi
    RESET Investigators
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2023, 102 (04) : 594 - 607
  • [37] LOCAT (low-dose computed tomography for appendicitis trial) comparing clinical outcomes following low-vs standard-dose computed tomography as the first-line imaging test in adolescents and young adults with suspected acute appendicitis: study protocol for a randomized controlled trial
    Ahn, Soyeon
    TRIALS, 2014, 15
  • [38] The CombiRx Trial: A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon Beta-1a and Glatiramer Acetate to Either Agent Alone in Participants with Relapsing-Remitting Multiple Sclerosis - Clinical Outcomes
    Lublin, Fred
    Cofield, Stacey
    Cutter, Gary
    Conwit, Robin
    Narayana, Ponnada
    Nelson, Flavia
    Gustafson, Tarah
    Wolinsky, Jerry
    NEUROLOGY, 2012, 78
  • [40] Joint models inform the longitudinal assessment of patient-reported outcomes in clinical trials: a simulation study and secondary analysis of the restrictive Vs. liberal fluid therapy for major abdominal surgery (RELIEF) randomized controlled trial
    Daza, Julian F.
    Mitani, Aya A.
    Alibhai, Shabbir M. H.
    Smith, Peter M.
    Kennedy, Erin D.
    Shulman, Mark A.
    Myles, Paul S.
    Wijeysundera, Duminda N.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2024, 176